Cold-adapted bacterial extracts as a source of anti-infective and antimicrobial compounds against Staphylococcus aureus

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Katz ML, Mueller LV, Polyakov M, Weinstock SF. Where have all the antibiotic patents gone? Nat. Biotechnol. 24, 1529–1531 (2006).
  Medline CASGoogle Scholar
• 2. Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol. Rev. 41, 276–301 (2017).•• Description of mechanisms of biofilm-based antibiotic resistance in pathogenic bacteria.
  Medline CASGoogle Scholar
• 3. Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322, 207–228 (2008).
  Medline CASGoogle Scholar
• 4. Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin. Microbiol. Rev. 31, pii:e00020-18 (2018). •• Shows the evolution of methicillin-resistant Staphylococcus aureus.
  MedlineGoogle Scholar
• 5. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell. Microbiol. 11, 1034–1043 (2009).
  Medline CASGoogle Scholar
• 6. Liu W, Li J, Cheng M et al. A surface-engineered polyetheretherketone biomaterial implant with direct and immunoregulatory antibacterial activity against methicillin-resistant Staphylococcus aureus. Biomaterials 208, 8–20 (2019).
  Medline CASGoogle Scholar
• 7. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42, 657–668 (2006).
  MedlineGoogle Scholar
• 8. Artini M, Papa R, Barbato G et al. Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds. Bioorg. Med. Chem. 20, 920–926 (2012).
  Medline CASGoogle Scholar
• 9. Manivasagan P, Kang KH, Sivakumar K, Li-Chan EC, Oh HM, Kim SK. Marine actinobacteria: an important source of bioactive natural products. Environ. Toxicol. Pharmacol. 38, 172–188 (2014).
  Medline CASGoogle Scholar
• 10. Mehbub MF, Lei J, Franco C, Zhang W. Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives. Mar. Drugs 12, 4539–4577 (2014).
  MedlineGoogle Scholar
• 11. Artini M, Patsilinakos A, Papa R et al. Antimicrobial and antibiofilm activity and machine learning classification analysis of essential oils from different Mediterranean plants against Pseudomonas aeruginosa. Molecules 23, pii:E482 (2018).
  MedlineGoogle Scholar
• 12. Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981–2002. J. Nat. Prod. 66, 1022–1037 (2003).
  Medline CASGoogle Scholar
• 13. Katz L, Baltz RH. Natural product discovery: past, present, and future. J. Ind. Microbiol. Biotechnol. 43, 155–176 (2016).
  Medline CASGoogle Scholar
• 14. Bhatnagar I, Kim SK. Immense essence of excellence: marine microbial bioactive compounds. Mar. Drugs 8, 2673–2701 (2010).
  Medline CASGoogle Scholar
• 15. Ng TB, Cheung RC, Wong JH, Bekhit AA, Bekhit Ael-D. Antibacterial products of marine organisms. Appl. Microbiol. Biotechnol. 99, 4145–4173 (2015).•• An overview of new antimicrobials isolated from marine organisms.
  Medline CASGoogle Scholar
• 16. Molinski TF, Dalisay DS, Lievens SL, Saludes JP. Drug development from marine natural products. Nat. Rev. Drug. Discov. 8, 69–85 (2009).
  Medline CASGoogle Scholar
• 17. Liu Y. Renaissance of marine natural product drug discovery and development. J. Mari. Sci. Res. Dev. 2, e106 (2012).
  Google Scholar
• 18. Lo Giudice A, Bruni V, Michaud L. Characterization of Antarctic psychrotrophic bacteria with antibacterial activities against terrestrial microorganisms. J. Basic Microbiol. 47, 496–505 (2007).
  MedlineGoogle Scholar
• 19. Núñez-Montero K, Barrientos L. Advances in Antarctic research for antimicrobial discovery: a comprehensive narrative review of bacteria from Antarctic environments as potential sources of novel antibiotic compounds against human pathogens and microorganisms of industrial importance. Antibiotics (Basel) 7, pii:E90 (2018). •• An overview of new antimicrobials isolated from Antarctic bacteria.
  MedlineGoogle Scholar
• 20. Neifar M, Maktouf S, Ghorbel RE, Jaouani A, Cherif A. Extremophiles as a source of novel bioactive compounds with industrial potential. In: Biotechnology of Bioactive Compounds: Sources and Applications. John Wiley & Sons, Chichester, West Sussex, UK (2015).
  Google Scholar
• 21. Papa R, Parrilli E, Sannino F et al. Anti-biofilm activity of the Antarctic marine bacterium Pseudoalteromonas haloplanktis TAC125. Res. Microbiol. 164, 450–456 (2013).
  Medline CASGoogle Scholar
• 22. Parrilli E, Papa R, Carillo S et al. Anti-biofilm activity of Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm: evidence of a signal molecule involvement? Int. J. Immunopathol. Pharmacol. 28, 104–113 (2015).
  Medline CASGoogle Scholar
• 23. Casillo A, Papa R, Ricciardelli A et al. Anti-biofilm activity of a long-chain fatty aldehyde from Antarctic Pseudoalteromonas haloplanktis TAC125 against Staphylococcus epidermidis biofilm. Front. Cell. Infect. Microbiol. 7, 46 (2017).• Describes a new small antibiofilm molecule isolated from an Antarctic bacterium.
  MedlineGoogle Scholar
• 24. Papaleo MC, Romoli R, Bartolucci G et al. Bioactive volatile organic compounds from Antarctic (sponges) bacteria. N. Biotechnol. 30, 824–838 (2013).
  Medline CASGoogle Scholar
• 25. Sannino F, Parrilli E, Apuzzo GA et al. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains. N. Biotechnol. 35, 13–18 (2017).
  Medline CASGoogle Scholar
• 26. Papa R, Selan L, Parrilli E et al. Anti-biofilm activities from marine cold adapted bacteria against Staphylococci and Pseudomonas aeruginosa. Front. Microbiol. 6, 1333 (2015). • Shows the antibiofilm activities of several polar bacteria against different pathogens.
  MedlineGoogle Scholar
• 27. CLSI Supplement M100. Performance Standards for Antimicrobial Susceptibility Testing (27th Edition). Clinical and Laboratory Standards Institute, Wayne, PA, USA (2017).
  Google Scholar
• 28. Busetti A, Shaw G, Megaw J, Gorman SP, Maggs CA, Gilmore BF. Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa. Mar. Drugs 13, 1–28 (2014).
  MedlineGoogle Scholar
• 29. Artini M, Papa R, Scoarughi GL et al. Comparison of the action of different proteases on virulence properties related to the staphylococcal surface. J. Appl. Microbiol. 114, 266–277 (2013).
  Medline CASGoogle Scholar
• 30. Liu XY, Yang SZ, Mu BZ. Production and characterization of a C15-surfactin-O-methyl ester by a lipopeptide producing strain Bacillus subtilis HSO121. Process Biochem. 44, 1144–1151 (2009).
  CASGoogle Scholar
• 31. Naruse N, Tenmyo O, Kobaru S et al. Pumilacidin, a complex of new antiviral antibiotics production, isolation, chemical properties, structure and biological activity. J. Antibiot. 43, 267–280 (1990).
  Medline CASGoogle Scholar
• 32. Saggese A, Culurciello R, Casillo A, Corsaro MM, Ricca E, Baccigalupi L. A marine isolate of Bacillus pumilus secretes a pumilacidin active against Staphylococcus aureus. Mar. Drugs 16, 180 (2018).
  Google Scholar
• 33. Inès M, Dhouha G. Lipopetide surfactants: production, recovery and pore forming capacity. Peptides 71, 100–112 (2015).
  Medline CASGoogle Scholar
• 34. Janek T, Łukaszewicz M, Rezanka T, Krasowska A. Isolation and characterization of two new lipopeptide biosurfactants produced by Pseudomonas fluorescens BD5 isolated from water from the Arctic Archipelago of Svalbard. Bioresour. Technol. 101, 6118–6123 (2010).
  Medline CASGoogle Scholar
• 35. Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D. Antibiotic discovery in the twenty-first century: current trends and future perspectives. J. Antibiot. 63, 423–430 (2010).
  Medline CASGoogle Scholar
• 36. Cafiso V, Bertuccio T, Santagati M et al. agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 51, 220–227 (2007).
  Medline CASGoogle Scholar
• 37. Wille JJ, Kydonieus A. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against Gram-positive bacteria. Skin Pharmacol. Appl. Skin Physiol. 16, 176–187 (2003).
  Medline CASGoogle Scholar
• 38. Drake DR, Brogden KA, Dawson DV, Wertz PW. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J. Lipid Res. 49, 4–11 (2008).
  Medline CASGoogle Scholar
• 39. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob. Agents Chemother. 2, 23–28 (1972).
  Medline CASGoogle Scholar
• 40. Kitahara T, Koyama N, Matsuda J et al. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 27, 1321–1326 (2004).
  Medline CASGoogle Scholar
• 41. Kelsey JA, Bayles KW, Shafii B, McGuire MA. Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 41, 951–961 (2006).
  Medline CASGoogle Scholar
• 42. Kamimura K, Fuse H, Takimura O, Yamaoka Y, Ohwada K, Hashimoto J. Pressure-induced alteration in fatty acid composition of barotolerant deep-sea bacterium. J. Oceanogr. 48, 104 (1992).
  Google Scholar
• 43. Ponder MA, Gilmour SJ, Bergholz PW et al. Characterization of potential stress responses in ancient Siberian permafrost psychroactive bacteria. FEMS Microbiol. Ecol. 53, 103–115 (2005).
  Medline CASGoogle Scholar
• 44. Das P, Mukherjee S, Sivapathasekaran C, Sen R. Microbial surfactants of marine origin: potentials and prospects. Adv. Exp. Med. Biol. 672, 88–101 (2010).
  Medline CASGoogle Scholar
• 45. Banat IM, Franzetti A, Gandolfi I et al. Microbial biosurfactants production, applications and future potential. Appl. Microbiol. Biotechnol. 87, 427–444 (2010).
  Medline CASGoogle Scholar
• 46. Biniarz P, Łukaszewicz M, Janek T. Screening concepts, characterization and structural analysis of microbial-derived bioactive lipopeptides: a review. Crit. Rev. Biotechnol. 8551, 1–18 (2016).• An overview of microbial-derived bioactive lipopeptides.
  Google Scholar
• 47. Nielsen TH, Nybroe O, Koch B, Hansen M, Sørensen J. Genes involved in cyclic lipopeptide production are important for seed and straw colonization by Pseudomonas sp. strain DSS73. Appl. Environ. Microbiol. 71, 4112–4116 (2005).
  Medline CASGoogle Scholar
• 48. Raaijmakers JM, de Bruijn I, de Kock MJ. Cyclic lipopeptide production by plant-associated Pseudomonas spp.: diversity, activity, biosynthesis, and regulation. Mol. Plant Microbe Interact. 19, 699–710 (2006).
  Medline CASGoogle Scholar
• 49. Janek T, Łukaszewicz M, Krasowska A. Antiadhesive activity of the biosurfactant pseudofactin II secreted by the Arctic bacterium Pseudomonas fluorescens BD5. BMC Microbiol. 12, 24 (2012).
  Medline CASGoogle Scholar
• 50. Ding L, Zhang S, Guo W, Chen X. Exogenous indole regulates lipopeptide biosynthesis in Antarctic Bacillus amyloliquefaciens Pc3. J. Microbiol. Biotechnol. 28, 784–795 (2018).
  Medline CASGoogle Scholar
• 51. Marty FM, Yeh WW, Wennersten CB et al. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J. Clin. Microbiol. 44, 595–597 (2006).
  Medline CASGoogle Scholar
• 52. Yang X, Huang E, Yuan C, Zhang L, Yousef AE. Isolation and structural elucidation of brevibacillin: an antimicrobial lipopeptide from Brevibacillus laterosporus that combats drug-resistant Gram-positive bacteria. Appl. Environ. Microbiol. 82, 2763–2772 (2016).• Describes the antimicrobial activity of a natural lipopeptide against drug-resistant Gram-positive bacteria.
  Medline CASGoogle Scholar
• 53. Groudieva T, Grote R, Antranikian G. Psychromonas arctica sp. nov., a novel psychrotolerant, biofilm-forming bacterium isolated from Spitzbergen. Int. J. Syst. Evol. Microbiol. 53, 539–545 (2003).
  Medline CASGoogle Scholar
• 54. Feller G, D’Amico S, Benotmane AM, Joly F, Van Beeumen J, Gerday C. Characterization of the C-terminal propeptide involved in bacterial wall spanning of alpha-amylase from the psychrophile Alteromonas haloplanktis. J. Biol. Chem. 273, 12109–12115 (1998).
  Medline CASGoogle Scholar